Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

被引:0
|
作者
Annette S Droste
David Rohde
Mirko Voelkers
Arthur Filusch
Thomas Bruckner
Mathias M Borst
Hugo A Katus
F Joachim Meyer
机构
[1] Angiology and Respiratory Medicine,Department of Cardiology
[2] Institute for Medical Biometry and Informatics of the University,undefined
来源
关键词
Bosentan; Systolic Pulmonary Artery Pressure; Idiopathic Pulmonary Arterial Hypertension; Pulmonary Hemodynamic; Expiratory Airflow;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Endothelin-1 dual receptor antagonist and the effect on platelet function in pulmonary arterial hypertension
    Davidson, S. J.
    Wort, S. J.
    Parfitt, L. A.
    Corte, T. J.
    Park, J.
    Harries, C.
    Gatzoulis, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 901 - 901
  • [32] Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
    Tynan, Timothy
    Hird, Kathryn
    Hannon, Tara
    Gabbay, Eli
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (05) : 2177 - 2186
  • [33] Dual endothelin receptor antagonism in pulmonary arterial hypertension
    Pittrow, D.
    Kirch, W.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : V - VI
  • [34] Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
    O'Callaghan, Dermot S.
    Savale, Laurent
    Yaici, Azzedine
    Natali, Delphine
    Jais, Xavier
    Parent, Florence
    Montani, David
    Humbert, Marc
    Simonneau, Gerald
    Sitbon, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (10) : 1585 - 1596
  • [35] Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension
    Langleben, David
    CLINICS IN CHEST MEDICINE, 2007, 28 (01) : 117 - +
  • [36] Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
    Tabeling, Christoph
    Calera, Carla Gonzalez R.
    Lienau, Jasmin
    Hoeppner, Jakob
    Tschernig, Thomas
    Kershaw, Olivia
    Gutbier, Birgitt
    Naujoks, Jan
    Herbert, Julia
    Opitz, Bastian
    Gruber, Achim D.
    Hocher, Berthold
    Suttorp, Norbert
    Heidecke, Harald
    Burmester, Gerd-R.
    Riemekasten, Gabriela
    Siegert, Elise
    Kuebler, Wolfgang M.
    Witzenrath, Martin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview
    Raja, Shahzad G.
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) : e65 - e71
  • [38] USE OF A NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST IN IDIOPATHIC PULMONARY HYPERTENSION
    Arkhipova, O. A.
    Martynyuk, T. V.
    Lazutkina, V. K.
    Ataullakhanova, D. M.
    Stukalova, O. V.
    Danilov, N. M.
    Samoilenko, L. E.
    Chazova, I. E.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (11) : 70 - 73
  • [39] Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan
    Humbert, M
    Cabane, J
    RHEUMATOLOGY, 2003, 42 (01) : 191 - 193
  • [40] The endothelin-receptor antagonist bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O
    Beghetti, M
    Petit, J
    Iserin, L
    Humbert, M
    Gressin, V
    Simonneau, G
    EUROPEAN HEART JOURNAL, 2004, 25 : 22 - 22